Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03079713 · ClinicalTrials.gov registry record · NA
Handheld Vibrator Versus Topical Eye Drops as Anesthesia for Intravitreal Injections
A NA study of Pain Control During Intravitreal Injections, sponsored by Wills Eye.
- Completed
- Registry status
- NA
- Development phase
- 110
- Enrollment target
- 1
- Study location
NCT03079713 is a NA study of Pain Control During Intravitreal Injections that has completed, run by Wills Eye. The registered enrollment target is 110 participants. The trial reports 1 study location across 1 state.
The verdict
NCT03079713, a NA study of Pain Control During Intravitreal Injections, has completed, sponsored by Wills Eye.
- COMPLETED
- Registry status
- NA
- Development phase
- 110 participants
- Enrollment target
- 1
- Study location
Study Summary
Intravitreal injections are an efficient method of delivering therapeutic levels of medications to the posterior segment of the eye. Prior to receiving an injection, there are various methods to provide ocular anesthesia. Vibration may have an anti-nociceptive effect by directly decreasing the sensitivity of peripheral nociceptors or by reducing signal transmission from peripheral nociceptors to the brain with activation of vibratory sensation pathways. The purpose of this study is to evaluate the use of a handheld fingertip vibrator compared to topical eye drops for pain control while performing intravitreal eye injections. A secondary objective of the study is to measure corneal and conjunctiva sensitivity with and without activation of the vibrator to the lower lid using a Luneau Cochet-Bonnet aesthesiometer.
Conditions Studied
Interventions
- DEVICE Handheld vibrator triggered during intravitreal injection for wet ARMD
- DEVICE Normal eye esthesiometry with and without vibration
- DEVICE Handheld vibrator not triggered during intravitreal injection for wet ARMD
Study Locations (1)
Pennsylvania
- MidAtlantic Retina-Wills Eye Hospital - Philadelphia
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 110 participants |
| Start Date | 2017-04-12 |
| Est. Completion | 2019-03-20 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03079713
The ClinicalTrials.gov registry entry for NCT03079713 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 110 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Wills Eye, which has 59 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Pain Control During Intravitreal Injections appearing as the primary indexed condition, and to 3 interventions - of which Handheld vibrator triggered during intravitreal injection for wet ARMD is the first listed.
NCT03079713 reports 1 study location spanning 1 distinct geographic area - top geographies include Pennsylvania.
Frequently Asked Questions
What is clinical trial NCT03079713 about?
NCT03079713 is a clinical study titled "Handheld Vibrator Versus Topical Eye Drops as Anesthesia for Intravitreal Injections". Intravitreal injections are an efficient method of delivering therapeutic levels of medications to the posterior segment of the eye. Prior to receiving an injection, there are various methods to provide ocular anesthesia. Vibration may have an anti-nociceptive effect by directly decreasing the sensi...
What is the current status of trial NCT03079713?
This trial is currently completed. It is a NA study. The enrollment target is 110 participants. The study started on 2017-04-12. Estimated completion is 2019-03-20.
What conditions does trial NCT03079713 study?
This clinical trial studies the following conditions: Pain Control During Intravitreal Injections.
What interventions are being tested in trial NCT03079713?
The interventions under investigation include: Handheld vibrator triggered during intravitreal injection for wet ARMD (DEVICE), Normal eye esthesiometry with and without vibration (DEVICE), Handheld vibrator not triggered during intravitreal injection for wet ARMD (DEVICE).
Who is sponsoring clinical trial NCT03079713?
This trial is sponsored by Wills Eye, which has 59 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03079713 being conducted?
This trial has 1 study location across Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.